Drug recall · June 29, 2016
Irbesartan and Hydrochlorothiazide Tablets recall
Why: Labeling: Incorrect or Missing Lot and/or Exp Date: Incorrect lot number, 327B160012, appears on the case label, the correct lot number, 327B16002 appears on the immediate container.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Irbesartan and Hydrochlorothiazide Tablets, USP, 300/12.5 mg, Rx only, Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd, Xunqiao, Linhai, Zhejiang 317024, China; Distributed by: Solco Healthcare U.S., LLC, Cranbury, NJ 08512, NDC 43547-331-09.
- Lots / codes
Lot #: 327B16002, Exp 12/17
- Quantity
- 60 bottles (5 cases)
- Company
- Prinston Pharmaceutical Inc, Cranbury, NJ
- Distribution
- Nationwide
- Initiated
- May 30, 2016 · Voluntary: Firm initiated
- Classified
- June 23, 2016
- Reported
- June 29, 2016
- Ended
- June 9, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydrochlorothiazide / irbesartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.